Pediatrics

The pediatric pharmacy resident will have opportunities to provide comprehensive clinical pharmacy services in neonatology, pediatric critical care, and general pediatrics. Pediatric ambulatory care clinic and research block rotation (taken as a single month or longitudinal throughout the year) and active participation in longitudinal clinics (½ day per week, year round) are also required. Three elective rotations (one-month duration) may be selected from available specialty areas such as obstetrics, infectious disease, hematology / oncology, emergency medicine, bone marrow transplant, and academia. Some, but no more than three, rotations may be completed off-site.

The following clinical pharmacy services are provided: education of patients / parents and members of the health care team; provision of verbal and written pharmacotherapeutic, pharmacokinetic, and nutritional support consultations; participation in the cardiac arrest team; and management of toxicology cases. The pediatric resident will participate in the in-house clinical pharmacy on-call program or have staffing responsibilities in the pediatric pharmacy satelite.

The pediatric pharmacy resident is also required to complete a research project during the residency. Previous pediatric residents have participated in original research projects including: the pharmacokinetics and pharmacogenomics of indomethacin for intraventricular hemorrhage prophylaxis, aminoglycoside dosing regimens in neonates and PICU patients, pediatric pharmacokinetics of vancomycin, perioperative antibiotic prescribing in neonates, and management of urinary tract infections in children older than 2 years. The results of research projects have been presented at scientific meetings and have been published in prestigious medical journals.

The pediatric resident will undertake some faculty responsibilities in the Department of Pharmacy Practice at the College of Pharmacy. The resident will have the opportunity to develop teaching skills by presenting seminars and in-service lectures to health care professionals and by interacting with pharmacy students during the clinical clerkship experience.

As with all ASHP-accredited PGY2 programs, the overall purpose of this residency is to “build on Doctor of Pharmacy education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.”

Qualified applicants must hold a Doctor of Pharmacy Degree and must be eligible for licensure in the state of Illinois. The applicant must have completed or be in the process of completing a Pharmacy Practice Residency (PGY 1). The yearly stipend is competitive.

Clinical

To assist the University of Illinois Hospital & Health Sciences System in providing 24-hour, clinical pharmacy coverage to all UIC patients, residents participate in the On-Call Program, which provides overnight and weekend clinical services. On-call activities typically include responding to “codes,” evaluating antibiotic therapies and adverse drug reactions; monitoring pharmacokinetics; and providing nutrition support and patient counseling services. Residents discuss their on-call cases during daily resident report meetings. Former UIC residents and fellows often identify this program as the most rewarding aspect of the pharmacy practice residency and the greatest contributing factor to their clinical skills development.

Teaching

• Experiential teaching and precepting of P1-P4 students
• Precepting of the PGY1 residents on pediatric rotations
• ACPE-accredited seminar
• Two lectures to P3 students in the “Pediatric Therapeutics” elective
• One lecture to P3 students in the “Critical Care” elective (optional)
• In-services (as needed)
• Teaching certificate program (if not previously completed)

Research

• IRB-approved research project to be presented at the Pediatric Pharmacy Association (PPA) annual meeting
• Manuscript development and submission

Requirements

• The PGY2 Residency requires a PharmD degree and completion of a PGY1 residency
• Pharmacist licensure in Illinois
• Ability to start the residency on July 1.

Required rotations

• Orientation/Operational Services
• General Pediatrics 1
• General Pediatrics 2
• Pediatric ICU
• Neonatal ICU 1
• Neonatal ICU 2
• Ambulatory Care
• Longitudinal ambulatory care

Elective rotations

• Emergency medicine
• Hematology – Oncology
• Solid Organ Transplant (Ann & Robert H. Lurie children’s hospital)
• Bone Marrow Transplant (Ann & Robert H. Lurie children’s hospital)
• High risk obstetrics
• Infectious disease/Antimicrobial Stewardship
• Academia

Leslie Briars, PharmD, FPPA
Clinical Associate Professor
Clinical Pharmacist – Pediatric Ambulatory Care

Kirsten Ohler, PharmD, FCCP, BCPPS
Clinical Associate Professor
Clinical Pharmacist – Neonatal Intensive Care Unit
Director, PGY1 Pharmacy Residency

Lauren Oliveri, PharmD, BCPPS
Clinical Assistant Professor
Clinical Pharmacist – Pediatrics, Pediatric Intensive Care Unit, Pediatric Oncology
Director, PGY2 Pediatric Residency

Jennifer Pham, PharmD, BCPS, BCPPS
Clinical Associate Professor
Clinical Pharmacist – Neonatal Intensive Care Unit

Sara Hovey, PharmD, BCPPS
Clinical Assistant Professor
Clinical Pharmacist – Pediatric, Pediatric Intensive Care Unit

2023 – 2024 Elizabeth Ferengul

Past Residents and Fellows

2020-2021 Corinne Songer, PharmD

2019-2020 Joette Amundaray Miller, PharmD

2018-2019 Michelle Lee, PharmD

2017-2018 Sana Said, PharmD, BCPPS

2016-2017 Sara (Brown) Hovey, PharmD, BCPPS

2015-2016 Duchess Domingo, PharmD

2014-2015 Bridget Hoy, PharmD

2013-2014 Cassandra Vandevoorde, PharmD

2012-2013 Deborah (Raithel) Bondi, PharmD, BCPS, BCPPS

2011-2012 Jessica Jacobson, PharmD, BCPS, BCPPS

2010-2011 Lauren (Dandeles) Oliveri, PharmD, BCPPS

2008 – 2009 Karen Caylor, PharmD

2007-2008 Palak Surti, PharmD

2006-2007 Najwa Al-Ghamedi, PharmD

2004-2006 Jennifer Morris, PharmD

2000-2001 Jennifer Raltz, PharmD

1997-1998 Preecha Montakantikul, PharmD

1996-1998 Tracy Sandritter, PharmD

1995-1996 Jennifer (Tran) Pham, PharmD, BCPS, BCPPS

1993-1995 Julie Everett, PharmD

1992-1994 Margaret (Campbell) Burke, PharmD

1991-1992 Cynthia Dusik, PharmD

1989-1991 Miriam (Marcadis) Kisch, PharmD

1986-1988 Tina Hatzopoulos, PharmD

1985-1986 Laura D’Oria, PharmD

1984-1985 Diana (Stapars) Pone, PharmD

1984-1985 Alice Kowalczyk, PharmD

1983-1984 Sharon Young, PharmD

1982-1983 Shirley (Mork) Reitz, PharmD

Since 1969, over 300 pharmacists successfully trained in our ASHP accredited first-year-post-graduate program. In addition, we have graduated over 100 individuals in our various specialized pharmacy residencies that encompass a wide range of fields that is second to none. Our diverse faculty, in combination with the numerous progressive practice sites, provides our residents with an experience like no other. Our residency alumnae hold prominent positions within pharmacy academia, industry, and professional organizations nationwide and are leaders in the world of pharmacy practice. We are proud of our tradition, our outcomes and our graduates and with the increasing expectations of the public and other health professional to improve the lives of patients, we are confident that our residency programs will grow and develop to meet this challenge.

The PGY1 Pharmacy Practice Residency has long provided unique and exceptional training experiences through its large number of rotation sites, preceptors, the on-call program and resident report. Coupled with the Residency Project, ACPE-accredited seminar and the Teaching Certificate program, this rigorous program provides a strong basis for multiple career pathways.

Publications

Abstracts Presented

• Songer CN, Bondi DS, Oliveri LM, Jarrett JB, Ohler KH. PharmD Survey of pediatric clinical pharmacist and
  trainee perceptions of post-graduate training path. Pediatric Pharmacy Association (PPA) Virtual
  Meeting, 2021.
• Miller JA, Porto I, Oliveri LM. Do providers appropriately complete a pediatric venous thromboembolism
  risk assessment tool? Pediatric Pharmacy Advocacy Group (PPAG) Virtual Meeting, 2020.
• Lee MM, Briars L, Ohler KH, Gross A, Oliveri LM. Evaluation of Outpatient Antibiotic Prescribing for
  Urinary Tract Infection in Pediatric Patients 2 Months to 18 Years Old Antibiotic Choice in Pediatric
  Urinary Tract Infection. Pediatric Pharmacy Advocacy Group (PPAG) Meeting, 2019.
• Said S, Pham J, Srinivasan N, Ohler K. Evaluation of Perioperative Antimicrobial Prophylaxis and Surgical
  Site Outcomes in the Neonatal Intensive Care Unit.  Platform presentation:  27 th  Annual
  Pediatric Pharmacy Advocacy Group (PPAG) Meeting & 2018 Pediatric Pharmacy Conference. Salt Lake
  City, Utah, April 25-29, 2018.
• Pham JT, Jacobson JL, Ohler KH, Kraus DM, Calip GS. Evaluation of the Risk Factors for Acute Kidney Injury in
  Preterm Neonates Exposed to Antenatal Indomethacin. J Pediatr Pharmacol Ther 2020;25(7):576-586.
• Brown SW, Oliveri L, Ohler KH, Briars L. Pediatric medication safety and the community pharmacist.Pediatric Pharmacy Advocacy Group, 26th Annual Conference, April 2017.
• Hoy B, Ohler KH, Pham JT, Raghavan A, Kraus DM. Antibiotic use in neonates exposed to chorioamnionitis: compliance with the American Academy of Pediatrics guidelines.  Pediatric Pharmacy Advocacy Group, 24th Annual Conference, April 2015.
• Raithel DS, Ohler KH, Pham JT, Cavallari LH, Maheshwari A, Kraus DM.  Neonatal indomethacin for prevention of intraventricular hemorrhage: a study of plasma concentrations, pharmacogenomic factors, and outcomes. Pediatric Pharmacy Advocacy Group, 22nd Annual Conference, April 2013.
• Jacobson JL, Pham JT, Ohler KH, Maheshwari A, Kraus DM. Evaluation of Acute Kidney Injury in Neonates Exposed to Antenatal Indomethacin. Pediatric Pharmacy Advocacy Group, 21st Annual Conference, April 2012.
• Dandeles L, Kopec K, Kraus D. Intravenous Levetiracetam for Pediatric Status Epilepticus, Acute Repetitive Seizures, and Neonatal Seizures. Pediatric Pharmacy Advocacy Group, 20th Annual Conference, March 2011.
• Caylor K, Ohler K, Rodvold K, Kraus D. Performance of a Neonatal Vancomycin Dosing Regimen. Pediatric Pharmacy Advocacy Group, Specialty Conference, April 2009.
• Surti PA, Pham JT, Kraus DM. The Use of Oral Sucrose for the Treatment of Neonatal Pain. Pediatric Pharmacy Advocacy Group, Specialty Conference for Neonatal and Pediatric Critical Care, April 2008.
• Morris JL, Briars LA, Kraus DM. Seven Years of Clinical Pharmacy Services in a Pediatric HIV Clinic. Pediatric Pharmacy Advocacy Group, 14th Annual Conference, October 2005. Abstract published in The Journal of Pediatric Pharmacology and Therapeutics 2005; 10:128-129.
• Collura JM, Stohlmeyer LA, Kraus DM. Analysis of Pediatric Labeling for Common Outpatient Pediatric Medications. American Society of Hospital Pharmacists 35th Annual Midyear Clinical Meeting, December 2000.
• Kraus DM, Sandritter TL, Stohlmeyer LA, Hannon PR. Potential Use of Liquid HIV Medications with the Rx medibottle®. Pediatric Pharmacy Advocacy Group, Seventh Annual Conference, October 1998. Abstract published in The Journal of Pediatric Pharmacy Practice 1998;3:290-1.
• Sandritter TL, Kraus DM. Estimated costs and lost charges from uncharted medications in a pediatric intensive care unit (PICU). American Society of Health-Care System Pharmacists, Midyear Clinical Meeting, December 1997.
• Everett JA, Kraus DM, Kecskes SA. Analysis of Averted Pediatric Medication Errors. Society for Pediatric Research, May 1995. Abstract published in Pediatric Research 1995;37:136A.
• Kraus DM, Dusik CM, Kecskes SA, Rodvold KA. Gentamicin Pharmacokinetics in Pediatric Intensive Care Unit Patients. American Society for Clinical Pharmacology and Therapeutics Ninety Forth Annual Meeting, March 1993.
• Marcadis ML, Kraus DM, Chow-Tung E, Young SL, McCulloch KM, Fischer JH. Effects of Maturation on Gentamicin Disposition in Neonates and Infants. American College of Clinical Pharmacy Eleventh Annual Meeting, August 1991. Abstract published in Pharmacotherapy 1991;11:269.

Manuscripts

• Raithel DS, Ohler KH, Porto I, Bicknese AR, Kraus DM. Morphine: an effective abortive therapy for severe pediatric paroxysmal sympathetic hyperactivity (autonomic storm). JPPT 2015;20(4):335-340.
• Morris JL, Kraus DM. New Antiretroviral Therapies for Pediatric HIV Infection. The Journal of Pediatric Pharmacology and Therapeutics 2005; 10:215-247.Collura JM, Kraus DM. New Pediatric Antiretroviral Agents. Journal of Pediatric Health Care 2000; 14:183-92.
• Rodvold KA, Everett JA, Pryka RD, Kraus DM. Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children.Clinical Pharmacokinetics 1997;33:32-51.
• Kraus DM, Campbell MM, Marcinak JF. Evaluation of Universal Hepatitis B Immunization Practices of Illinois Pediatricians. Archives of Pediatrics and Adolescent Medicine 1994;148:936-942.
• Campbell MM, Taeubel MA, Kraus DM. Updated Bedside Charts for Calculating Pediatric Doses of Emergency Medications. American Journal of Hospital Pharmacy1994;51:2147-2152.
• Kraus DM, Hatzopoulos FK, Reitz SJ, Fischer JH. Pharmacokinetic Evaluation of Two Theophylline Dosing Methods for Infants. Therapeutic Drug Monitoring 1994;16:270-276.
• Kraus DM, Dusik CM, Rodvold KA, Campbell MM, Kecskes SA. Bayesian Forecasting of Gentamicin Pharmacokinetics in Pediatric Intensive Care Unit Patients. Pediatric Infectious Disease Journal1993;12:713-8.
• Marcadis ML, Kraus DM, Hatzopoulos FK, John EG. Use of Enalaprilat for Neonatal Hypertension. Journal of Pediatrics 1991;119:505 (Letter).